Skip to main content

Research Repository

Advanced Search

Percutaneous coronary intervention of saphenous vein grafts: where do we stand?

Bulluck, Heerajnarain; Bagur, Rodrigo; Mamas, Mamas A.

Authors

Heerajnarain Bulluck

Rodrigo Bagur



Abstract

Saphenous vein grafts (SVG) are known to be more susceptible to accelerated atherosclerosis than native coronary arteries1. Accelerated atherosclerosis in SVG develops from resident foam cells, which then undergo apoptosis to form necrotic cores1. The attrition rate of SVG is around 2% per year for the first seven years, rising to 5% per year thereafter. Less than half of all SVG remain patent by 10 years. SVG intervention is usually undertaken in a group of patients carrying a higher risk profile, accounting for around 10% of all percutaneous coronary intervention (PCI) cases1.

Citation

Bulluck, H., Bagur, R., & Mamas, M. A. (2018). Percutaneous coronary intervention of saphenous vein grafts: where do we stand?. EuroIntervention, 14(2), 142-143. https://doi.org/10.4244/EIJV14I2A22

Journal Article Type Article
Publication Date 2018-06
Deposit Date Jun 26, 2023
Journal EUROINTERVENTION
Print ISSN 1774-024X
Publisher EuroPCR
Peer Reviewed Peer Reviewed
Volume 14
Issue 2
Pages 142-143
DOI https://doi.org/10.4244/EIJV14I2A22